Evidence File 039 · Psyllium Fibre · Method v0.14 of 4 claims researched

Psyllium FibrePlantago ovata husk · 4 claims

The best-evidenced supplement on this site, and the least marketed. Cheap, boring, and it does what it says.

4Claims scored

5Sources

10.2 gStudied dose

Jul 26Reviewed

Claim 01

Lowers LDL cholesterol

8.7/10

Strong·Replicated across three decades · GRADE assessed

A 2018 systematic review and meta-analysis in the American Journal of Clinical Nutrition pooled randomised trials of at least three weeks in people with and without high cholesterol, at a median dose of 10.2 g/day, and assessed the overall quality of evidence using GRADE.

The finding is not new and it has not moved. A 1997 meta-analysis found psyllium-enriched cereals lowered total and LDL cholesterol but not HDL in hypercholesterolaemic adults. A 1999 meta-analysis reached the same conclusion for dietary fibre generally. Effects have been replicated in children and adolescents as well as adults.

The mechanism is understood: increased bile acid excretion and reduced cholesterol absorption in the intestine.

The working

9Quantity

8Quality

9Consistency

9Directness

(9 × 0.25) + (8 × 0.35) + (9 × 0.25) + (9 × 0.15) = 8.7
The highest score on the site. Multiple independent meta-analyses spanning 1997 to 2018 agree on direction and magnitude, with a plausible mechanism.

MetaJovanovski E, Yashpal S, Komishon A, Zurbau A, Blanco Mejia S, Ho HVT, et al. Effect of psyllium fiber on LDL cholesterol and alternative lipid targets Am J Clin Nutr 2018;108:922-32 · doi 10.1093/ajcn/nqy115
MetaAssociations between dietary fiber intake and cardiovascular risk factors: umbrella review of meta-analyses of RCTs Collates Olson 1997, Brown 1999 and subsequent syntheses

Claim 02

Lowers apolipoprotein B and non-HDL cholesterol

7.1/10

Moderate·The better cardiovascular risk markers

The 2018 analysis was designed specifically to go beyond LDL and assess non-HDL cholesterol and apolipoprotein B, at the same median dose of 10.2 g/day.

This matters more than it sounds. ApoB counts the number of atherogenic particles rather than the cholesterol carried inside them, and it tracks cardiovascular risk better than LDL cholesterol does. A supplement that moves apoB is doing something more relevant than one that moves LDL alone.

The working

6Quantity

7Quality

7Consistency

9Directness

(6 × 0.25) + (7 × 0.35) + (7 × 0.25) + (9 × 0.15) = 7.1
Directness is 9 and matters here: apoB is a closer proxy for cardiovascular risk than LDL alone, so moving it is more meaningful, not less.

MetaJovanovski E, et al. Non-HDL cholesterol and apolipoprotein B outcomes Am J Clin Nutr 2018;108:922-32

Claim 03

Relieves constipation

7.2/10

Moderate·Consistent · and the reason most people take it

Dose-response meta-analysis reports that psyllium relieves constipation symptoms alongside reductions in body weight, glycaemic measures and cholesterol, with trials in chronic constipation and type 2 diabetes.

The adverse event profile is honest and unglamorous: heartburn, bloating, flatulence, abdominal cramps, dyspepsia, nausea and occasionally worsened haemorrhoids. Most are dose-related. Starting low and increasing gradually is the standard approach.

The working

7Quantity

6Quality

8Consistency

9Directness

(7 × 0.25) + (6 × 0.35) + (8 × 0.25) + (9 × 0.15) = 7.2
Well established and mechanistically obvious. Quality held at 6 because much of the constipation evidence sits inside trials designed to test other outcomes.

MetaThe beneficial effects of psyllium on cardiovascular diseases and their risk factors: systematic review and dose-response meta-analysis of RCTs Constipation, glycaemic and lipid outcomes with adverse event summary

Claim 04

Lowers blood pressure

6.5/10

Moderate·Dose-response meta-analysis · modest effect

A 2024 systematic review and dose-response meta-analysis examined psyllium and blood pressure specifically. The broader picture is that viscous soluble fibre lowers both systolic and diastolic pressure, a finding that goes back to a 2005 meta-analysis of dietary fibre and blood pressure.

The effect is modest. Its value is that it stacks with the lipid and glycaemic effects from the same intervention, rather than requiring a separate product for each.

The working

6Quantity

6Quality

6Consistency

9Directness

(6 × 0.25) + (6 × 0.35) + (6 × 0.25) + (9 × 0.15) = 6.5
Consistent in direction with a plausible shared mechanism across viscous soluble fibres. Smaller and less certain than the lipid effect.

MetaGholami et al. The effect of psyllium consumption on blood pressure: systematic review and dose-response meta-analysis of RCTs Food Sci Nutr 2024 · doi 10.1002/fsn3.3863

Dosage as studied

Most-studied regimen

10.2 g per day, median trial dose

Trials ranged from 2.4 to 20.4 g/day, with a minimum duration of three weeks.

Studied range: 2.4 to 20.4 g/day, median 10.2 g/day, in trials of at least three weeks.
Mechanism: Increased bile acid excretion and reduced intestinal cholesterol absorption. Not a mystery pathway.
Start low: Common adverse events are bloating, flatulence, cramping and dyspepsia. These are dose-related and usually settle.
Take with water: Bulk-forming fibre requires adequate fluid. It is also worth separating from medications, since bulking agents can affect absorption.